Literature DB >> 8233571

In vitro antimicrobial susceptibility to combinations of drugs on bacteria from carious and endodontic lesions of human deciduous teeth.

T Sato1, E Hoshino, H Uematsu, T Noda.   

Abstract

The purpose of this study was to clarify the antibacterial efficacy of mixed antibacterial drugs on bacteria of carious and endodontic lesions of human deciduous teeth in vitro. The antibacterial drugs used in this study were mixtures of ciprofloxacin, metronidazole, plus a third antibiotic: amoxicillin, cefaclor, cefroxadine, fosfomycin or rokitamycin. Samples taken from carious dentin (17 cases) and infected pulpal tissues (14 cases) were cultured on control plates and plates containing the mixed drugs. No bacteria were recovered in the presence of any combination of the mixture of the drugs (100 micrograms each/ml), and the bacterial growth occurred on control plates (10(1) to 10(7) colony-forming units), indicating that the mixed drugs inhibit the growth of bacteria in the samples. When carious and endodontic lesions on split surfaces of freshly extracted teeth were covered overnight with alpha-tricalcium phosphate cement containing a mixture of ciprofloxacin, metronidazole and cefaclor (1% each; 5 cases), no bacteria were recovered from the lesions. No bacteria were recovered from carious and endodontic lesions when these lesions were immersed in a solution of the mixture (200 micrograms each/ml; 5 cases). These findings indicate that carious and endodontic lesions can be sterilized by the mixed drugs in situ.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8233571     DOI: 10.1111/j.1399-302x.1993.tb00661.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  24 in total

Review 1.  Endodontic-periodontal locally delivered antibiotics.

Authors:  Amela Lacević; Edina Vranić; Irfan Zulić
Journal:  Bosn J Basic Med Sci       Date:  2004-02       Impact factor: 3.363

Review 2.  The microbial challenge to pulp regeneration.

Authors:  A F Fouad
Journal:  Adv Dent Res       Date:  2011-07

3.  Comparative Evaluation of Antimicrobial Effect of Three Endodontic Sealers with and Without Antibiotics - An In-vitro Study.

Authors:  Amulya Vanapatla; Harikumar Vemisetty; Rajani Punna; Chandrasekhar Veeramachineni; Ravichandra Polavarapu Venkata; Jaya Nagendra Krishna Muppala; Ramkiran Dandolu
Journal:  J Clin Diagn Res       Date:  2016-04-01

4.  Evaluation of the antimicrobial efficacy of two combinations of drugs on bacteria taken from infected primary teeth (in vitro).

Authors:  R Rafatjou; R Yousefimashouf; M Farhadian; S Afzalsoltani
Journal:  Eur Arch Paediatr Dent       Date:  2019-05-23

5.  Bioactive nanofibrous scaffolds for regenerative endodontics.

Authors:  M C Bottino; K Kamocki; G H Yassen; J A Platt; M M Vail; Y Ehrlich; K J Spolnik; R L Gregory
Journal:  J Dent Res       Date:  2013-09-20       Impact factor: 6.116

6.  Determination of crown discoloration and fluorescence induced by different medications used in regenerative endodontic procedures: An ex vivo study.

Authors:  Pablo Betancourt; Cristina Bucchi; Sebastiana Arroyo-Bote
Journal:  J Clin Exp Dent       Date:  2021-08-01

7.  Nonsurgical management of periapical lesions.

Authors:  Marina Fernandes; Ida de Ataide
Journal:  J Conserv Dent       Date:  2010-10

8.  Nonsurgical endodontic retreatment of advanced inflammatory external root resorption using mineral trioxide aggregate obturation.

Authors:  Shivani Utneja; Gaurav Garg; Shipra Arora; Sangeeta Talwar
Journal:  Case Rep Dent       Date:  2012-12-11

9.  Platelet-rich plasma supplemented revascularization of an immature tooth associated with a periapical lesion in a 40-year-old man.

Authors:  Ganesh Ranganath Jadhav; Naseem Shah; Ajay Logani
Journal:  Case Rep Dent       Date:  2014-02-20

10.  Antifungal effectiveness of various intracanal medicaments against Candida albicans: an ex-vivo study.

Authors:  Eu Gene Chua; Abhishek Parolia; Priya Ahlawat; Allan Pau; Fabian Davamani Amalraj
Journal:  BMC Oral Health       Date:  2014-05-13       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.